New opportunities in pancreatic cancer: RAS inhibitors, highly complex surgery and integrated care
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is taking part in the development of new RAS inhibi...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is taking part in the development of new RAS inhibi...
For the first time, the list includes a female researcher from the Campus, oncologist Ana Arance.
The Radiation Oncology team at Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), has used a single do...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre, is joining the 12th Cities Race against Pancreatic Cancer...
Ten projects involving researchers from Campus Clínic, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), have been se...
A new care model integrated into the Clínic Barcelona Comprehensive Cancer Centre (4CB) to identify genetic predisposition to cancer, strengthen pr...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), has played a prominent role at the European Society...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), took part in the national congress of the Spanish S...
The Clínic Barcelona Comprehensive Cancer Centre (4CB) has appointed Dr Susana Puig as Director of Research and Dr Teresa Macarulla as Director of...
The event addressed new treatments, patients’ quality of life and innovative studies such as the DIANA-Breastyle trial, which analyses the impact o...